CRISPR Therapeutics AG (CRSP) EPS (Basic) (2015 - 2026)
CRISPR Therapeutics AG (CRSP) posted EPS (Basic) of -$1.28 for Q1 2026, up 29.06% sequentially from -$1.8 in Q4 2025, and up 19.12% YoY from -$1.07 in Q1 2025.
CRISPR Therapeutics AG (CRSP) EPS (Basic) (2015 - 2026) Analysis & Trends
CRISPR Therapeutics AG has reported EPS (Basic) for 12 years, with the latest figure at -$1.28 in Q1 2026.
- Quarterly EPS (Basic) rose 19.12% year-over-year to -$1.28 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$6.25 (down 3044.61% YoY) and the FY2025 annual result came in at -$6.82, down 1628.11% from the prior year.
- EPS (Basic) climbed to -$1.28 in Q1 2026 per CRSP's latest filing, from -$1.8 in the prior quarter.
- Over five years, EPS (Basic) peaked at $4.35 in Q4 2024 and troughed at -$2.4 in Q2 2022.
- A 5-year average of -$1.07 and a median of -$1.42 in 2022 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2024 and 2025: EPS (Basic) soared 285.11% in 2024, then tumbled 141.52% in 2025.
- Over 5 years, EPS (Basic) stood at -$1.42 in 2022, then surged by 179.34% to $1.13 in 2023, then jumped by 285.11% to $4.35 in 2024, then sank by 141.52% to -$1.8 in 2025, then grew by 29.06% to -$1.28 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$1.28, -$1.8, and -$1.17 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | CRISPR Therapeutics AG | 5.18 Bn | 5.18 Bn | - | -0.94 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.94 |
| Mar 31, 2026 | -1.28 |
| Dec 31, 2025 | -1.80 |
| Sep 30, 2025 | -1.17 |
| Jun 30, 2025 | -2.40 |
| Mar 31, 2025 | -1.58 |
| Dec 31, 2024 | 4.35 |
| Sep 30, 2024 | -1.01 |
| Jun 30, 2024 | -1.49 |
| Mar 31, 2024 | -1.43 |
| Dec 31, 2023 | 1.13 |
| Sep 30, 2023 | -1.41 |
| Jun 30, 2023 | -0.98 |
| Mar 31, 2023 | -0.67 |
| Dec 31, 2022 | -1.42 |
| Sep 30, 2022 | -2.24 |
| Jun 30, 2022 | -2.40 |
| Mar 31, 2022 | -2.32 |
| Dec 31, 2021 | -1.86 |
| Sep 30, 2021 | -1.67 |